What is the Impact Factor of Oncotarget?

The journal Oncotarget is indexed in Web of Science (SCIE, quartile Q1) with official metrics continually updated on ImpaQ.

Is Oncotarget indexed in Web of Science or Scopus?

Yes, Oncotarget is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.828 (Q2) and an H-index of 201.

Who publishes Oncotarget and what is the Article Processing Charge (APC)?

Oncotarget is published by Impact Journals LLC. The estimated Article Processing Charge (APC) is approximately $3,219 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Oncotarget?

The official ISO-4 abbreviation of Oncotarget is "ONCOTARGET". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q2SCImago #6,575Subscription

Oncotarget

Abbreviation (ISO):ONCOTARGET

•

Identifier (ISSN):1949-2553(Print)

•

Publisher:Impact Journals LLC

Clarivate JCR Index Advisory: Not Indexed in Latest JCR

Official Website Submission Portal Compare

Clarivate Impact Factor (IF 2024)

N/A

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

Impact Factor Trend (2023–2025)

Clarivate IF trend for Oncotarget

WoS Q1

Annual Impact Factor Metric

Current (2025):0

Scopus SJR & RankScopus Q2

0.828

#6,575

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

201

201 papers with at least that number of citations each

WoS: SCIE / JCRQ1

Self-Citation RateN/A

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessSubscription

6,625articles/year

0% Gold OA•0% Original Research

Aims & Scope

Information not localized

Topics Covered (Recognized by AI)

Medicine98.6%Biology97%Genetics93.4%Internal medicine89.9%Chemistry81.3%Biochemistry79.9%Cancer research66.1%Cancer62.2%Gene58.8%Pathology44.4%Cell biology39.3%Immunology34.5%Oncology32.2%Apoptosis29.5%Surgery24.7%

Primary Research Areas

Oncogenes Cell Biology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR

No WoS category details available for this journal.

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF—

Articles / Year86

Total Citations11

2025

IF0

Articles / Year132

Total Citations225

2024

IF0

Articles / Year127

Total Citations519

2023

IF0

Articles / Year180

Total Citations1,099

2022

IF—

Articles / Year149

Total Citations1,071

Year	Impact Factor	Articles / Year	Total Citations
2026	—	86	11
2025	0	132	225
2024	0	127	519
2023	0	180	1,099
2022	—	149	1,071
2021	—	296	3,407
2020	—	472	7,261
2019	—	800	12,563
2018	—	2,643	61,988
2017	—	9,184	304,418
2016	—	7,598	320,959
2015	—	3,835	187,906

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #6,575Scopus Q2SCImago Profile

Scopus Coverage:2010-2026

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q2

0.828

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

1.89

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,219 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations765

3-Year Documents390

Citable Documents320

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate36.4%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

OncologyQ2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

Updating

Minor Category (Specific Field):

Updating

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Oncotarget (abbr: ONCOTARGET, ISSN: 1949-2553) is a peer-reviewed international scholarly journal in the field of Oncogenes, published by Impact Journals LLC in United States since 2009. The periodical holds tracked under Web of Science (SCIE) in quartile Q1, a Scopus SJR indicator of 0.828 (Q2), an H-index of 201.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 6,625 scientific articles. In terms of accessibility and author fees, it operates under the Subscription model with an estimated APC of $3,219 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.